KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Capital Leases (2016 - 2018)

Charles River Laboratories International has reported Capital Leases over the past 9 years, most recently at $29.2 million for Q4 2018.

  • Quarterly results put Capital Leases at $29.2 million for Q4 2018, down 3.5% from a year ago — trailing twelve months through Dec 2018 was $29.2 million (down 3.5% YoY), and the annual figure for FY2018 was $29.2 million, down 3.5%.
  • Capital Leases for Q4 2018 was $29.2 million at Charles River Laboratories International, down from $30.8 million in the prior quarter.
  • Over the last five years, Capital Leases for CRL hit a ceiling of $35.8 million in Q2 2015 and a floor of $717000.0 in Q1 2014.
  • Median Capital Leases over the past 5 years was $30.3 million (2017), compared with a mean of $26.2 million.
  • Biggest five-year swings in Capital Leases: soared 3428.59% in 2015 and later dropped 19.27% in 2016.
  • Charles River Laboratories International's Capital Leases stood at $1.0 million in 2014, then skyrocketed by 3260.0% to $33.6 million in 2015, then fell by 11.01% to $29.9 million in 2016, then rose by 1.34% to $30.3 million in 2017, then fell by 3.5% to $29.2 million in 2018.
  • The last three reported values for Capital Leases were $29.2 million (Q4 2018), $30.8 million (Q3 2018), and $30.6 million (Q2 2018) per Business Quant data.